Clinical Insights

Abstract: Recent publications have demonstrated that transradial access is safe and well tolerated in a heterogeneous patient population across a wide range of peripheral vascular interventions. Both the transradial and transulnar approach offer possible advantages in catheterization of intra-… Read More
Peiman Habibollahi, MD, is a resident of radiology at the Hospital of the University of Pennsylvania in Philadelphia. At the 2016 annual scientific meeting of the Society for Interventional Radiology (SIR), he presented outcomes from a study he conducted with colleagues at the University of… Read More
Adam D. Talenfeld, MD, is an attending physician at Weill Cornell Medical Center, New York Presbyterian Hospital in New York and a member of the Society of Interventional Radiology Foundation Quality and Outcomes Division’s Comparative Effectiveness Subcommittee. At the 2016 Annual Scientific… Read More
ABSTRACT: Purpose: This article aims to review radioembolization-specific coding guidelines so that interventional radiologists can develop a better understanding of what documentation is essential in their reports, leading to appropriate authorization and reimbursement. Background: Over the past… Read More
Alexander Sheu, MD, and Gloria Hwang, MD, from Stanford University studied the effect of microwave ablation on portal vein and hepatic vein thrombosis in hepatocellular carcinoma and liver metastases. They spoke with Interventional Oncology 360 about their study at the 2016 Annual Scientific… Read More
Joseph Kallini, MD, is a clinical research fellow at Northwestern University in the department of radiology, section of interventional radiology. His research mentor is Riad Salem MD, MBA, Chief of Interventional Radiology. At the 2016 Annual Scientific Meeting of the Society of Interventional… Read More
Abstract: Yttrium-90 selective internal radiation therapy (SIRT) is a treatment modality used for unresectable hepatic neoplasm, typically from primary hepatic malignancy such as hepatocellular carcinoma or colorectal and neuroendocrine metastases. Although extensive literature exists about SIRT… Read More
Editor's note: See related video here. Riad Salem, MD, chief of interventional radiology at Northwestern University, spoke with Interventional Oncology 360 at the 41st annual scientific meeting of the Society for Interventional Radiology about results of a prospective randomized phase 2 study of… Read More
Abstract: Background: Yttrium-90 (Y90) is increasingly used to treat both primary and secondary liver tumors that are ineligible for resection. In the United States, Y90 resin microspheres (SIR-Spheres; Sirtex Medical) are FDA approved for the treatment of nonresectable colorectal metastases with… Read More
Abstract: Cryoablation is a well established, FDA approved, minimally invasive treatment modality for fibroadenomas. Additionally, several pilot studies have shown its success in the treatment of small breast cancers. It is an outpatient office procedure performed percutaneously by placing a… Read More